[go: up one dir, main page]

BR0010150A - Solução oral de prucalopride - Google Patents

Solução oral de prucalopride

Info

Publication number
BR0010150A
BR0010150A BR0010150-8A BR0010150A BR0010150A BR 0010150 A BR0010150 A BR 0010150A BR 0010150 A BR0010150 A BR 0010150A BR 0010150 A BR0010150 A BR 0010150A
Authority
BR
Brazil
Prior art keywords
prucalopride
oral solution
solution
oral
pharmaceutically acceptable
Prior art date
Application number
BR0010150-8A
Other languages
English (en)
Other versions
BRPI0010150B8 (pt
BRPI0010150B1 (pt
Inventor
Eddy Andre Josee De Proost
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR0010150A publication Critical patent/BR0010150A/pt
Publication of BRPI0010150B1 publication Critical patent/BRPI0010150B1/pt
Publication of BRPI0010150B8 publication Critical patent/BRPI0010150B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "SOLUçãO ORAL DE PRUCALOPRIDE". A presente invenção refere-se a uma solução oral aquosa compreendendo prucalopride, ou seus sais ácidos de adição farmaceuticamente aceitáveis, com boas propriedades organolépticas.
BRPI0010150A 1999-04-29 2000-04-20 solução oral de prucalopride BRPI0010150B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (3)

Publication Number Publication Date
BR0010150A true BR0010150A (pt) 2002-01-15
BRPI0010150B1 BRPI0010150B1 (pt) 2015-06-23
BRPI0010150B8 BRPI0010150B8 (pt) 2021-05-25

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0010150A BRPI0010150B8 (pt) 1999-04-29 2000-04-20 solução oral de prucalopride

Country Status (36)

Country Link
US (1) US6413988B1 (pt)
EP (1) EP1176982B1 (pt)
JP (1) JP4773619B2 (pt)
KR (1) KR100669175B1 (pt)
CN (1) CN1165345C (pt)
AR (1) AR023815A1 (pt)
AT (1) ATE254929T1 (pt)
AU (1) AU770073B2 (pt)
BG (1) BG65061B1 (pt)
BR (1) BRPI0010150B8 (pt)
CA (1) CA2371178C (pt)
CZ (1) CZ294070B6 (pt)
DE (1) DE60006799T2 (pt)
DK (1) DK1176982T3 (pt)
EA (1) EA003904B1 (pt)
EE (1) EE05264B1 (pt)
ES (1) ES2211546T3 (pt)
HK (1) HK1045950B (pt)
HR (1) HRP20010764B1 (pt)
HU (1) HU228924B1 (pt)
ID (1) ID30397A (pt)
IL (2) IL146152A0 (pt)
JO (1) JO2181B1 (pt)
MX (1) MXPA01010953A (pt)
MY (1) MY119880A (pt)
NO (1) NO331448B1 (pt)
NZ (1) NZ515119A (pt)
PL (1) PL195674B1 (pt)
PT (1) PT1176982E (pt)
SI (1) SI1176982T1 (pt)
SK (1) SK284847B6 (pt)
TR (1) TR200103121T2 (pt)
TW (1) TW592709B (pt)
UA (1) UA68426C2 (pt)
WO (1) WO2000066170A1 (pt)
ZA (1) ZA200108820B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
WO2002041918A2 (en) * 2000-11-24 2002-05-30 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1789067B8 (en) 2004-08-12 2012-08-15 Helsinn Healthcare S.A. Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system
GB201103397D0 (pt) * 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations
CN119700664B (zh) * 2025-02-28 2025-06-20 山东新时代药业有限公司 含有活性成分琥珀酸普芦卡必利的注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
CA2352278A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica, N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
IL146152A0 (en) 2002-07-25
NO20014794D0 (no) 2001-10-02
CA2371178C (en) 2008-03-25
TR200103121T2 (tr) 2002-05-21
TW592709B (en) 2004-06-21
BRPI0010150B8 (pt) 2021-05-25
PT1176982E (pt) 2004-04-30
DK1176982T3 (da) 2004-03-29
BG65061B1 (bg) 2007-01-31
HK1045950A1 (en) 2002-12-20
EA003904B1 (ru) 2003-10-30
NO331448B1 (no) 2012-01-02
HRP20010764A2 (en) 2002-12-31
MXPA01010953A (es) 2002-05-06
CZ294070B6 (cs) 2004-09-15
SK15192001A3 (sk) 2002-03-05
US6413988B1 (en) 2002-07-02
HRP20010764B1 (hr) 2011-01-31
PL352062A1 (en) 2003-07-28
CA2371178A1 (en) 2000-11-09
AR023815A1 (es) 2002-09-04
HU228924B1 (en) 2013-06-28
ES2211546T3 (es) 2004-07-16
EE05264B1 (et) 2010-02-15
EP1176982A1 (en) 2002-02-06
HUP0202324A2 (hu) 2002-12-28
DE60006799D1 (de) 2004-01-08
UA68426C2 (uk) 2004-08-16
CN1165345C (zh) 2004-09-08
EP1176982B1 (en) 2003-11-26
CZ20013735A3 (cs) 2002-02-13
PL195674B1 (pl) 2007-10-31
NZ515119A (en) 2003-05-30
AU770073B2 (en) 2004-02-12
KR20020004972A (ko) 2002-01-16
NO20014794L (no) 2001-10-02
HUP0202324A3 (en) 2003-03-28
JP4773619B2 (ja) 2011-09-14
EA200101150A1 (ru) 2002-04-25
WO2000066170A1 (en) 2000-11-09
JP2002543161A (ja) 2002-12-17
MY119880A (en) 2005-07-29
SI1176982T1 (en) 2004-04-30
HK1045950B (zh) 2005-05-27
KR100669175B1 (ko) 2007-01-17
SK284847B6 (sk) 2006-01-05
BG106031A (en) 2002-05-31
AU4913700A (en) 2000-11-17
ZA200108820B (en) 2003-01-27
IL146152A (en) 2006-12-31
ID30397A (id) 2001-11-29
EE200100539A (et) 2002-12-16
BRPI0010150B1 (pt) 2015-06-23
CN1348386A (zh) 2002-05-08
JO2181B1 (en) 2003-04-23
ATE254929T1 (de) 2003-12-15
DE60006799T2 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
DE50011582D1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CA2391076A1 (en) Solutions containing epinastin
SE0001899D0 (sv) New compounds
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BR0010150A (pt) Solução oral de prucalopride
BR0012696A (pt) Composição oftálmica
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
EP1219296A4 (en) MEANS TO INHIBIT SEBUM PRODUCTION
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.
BR0013651A (pt) Tratamento de enxaqueca pela administração de ácido alfalipóico ou seus derivados
NO20013544L (no) Middel for å behandle Parkinsons sykdom samt anvendelse derav
EP1236712A4 (en) Amidinophenylpyruvic acid DERIVATIVE
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
IT1306186B1 (it) Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
IL160162A0 (en) Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives
SE9902674D0 (sv) New composition
HN2002000112A (es) Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/06/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/04/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 20/04/2020